Content area

|
|

Genomet og forbrugeren

Forfatter(e)
Gunna Christiansen Institut for Biomedicin, Aarhus Universitet Ugeskr Læger 2014;176:V06140342
Reference: 
Ugeskr Læger 2014;176:V06140342
Blad nummer: 
Sidetal: 
2152-2155
The genome and the consumer
Consumergenetics has developed so fast that it became possible for consumers to obtain genome risk information based on single nucleotide polymorphisms data of over 250 diseases/conditions for just 99 USD. In November 2013, the American Food and Drug Administration (FDA) ordered the company 23andMe to stop returning health results because they found a lack of scientific evidence of the reposted disease risks. The ethical dilemmas associated with this are reviewed, and the recommendations are described in genome testing. Ethical dilemmas in relation direct-to-consumer testing are discussed.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Gert Frank Thomsen | 17/02
1 Kommentar
af Kaare Rossel | 17/02
1 Kommentar
af Niels Rokkjær | 16/02
1 Kommentar
af Niels Egund | 15/02
2 kommentarer
af Astrid Hanna M. Schulze | 14/02
1 Kommentar
af Jens Gram-Hansen | 11/02
3 kommentarer
af Poul Erik Rørbæk | 11/02
1 Kommentar